ADMA BIOLOGICS, INC. Shareholders' Equity
ADMA BIOLOGICS, INC. (ADMA) had Shareholders' Equity of $408.21 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity Attributable to Parent $408.21M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $390.32M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $477.32M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $431.19M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $408.21M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $390.32M 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $477.32M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $431.19M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $398.32M 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $373.42M 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $349.02M 10-Q · filed 2026-08-05 | |
| 2024-09-30 | $231.89M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $188.27M 10-Q · filed 2025-11-05 | |
| 2024-03-31 | $153.71M 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $135.21M 10-K · filed 2026-02-25 | |
| 2023-09-30 | $151.44M 10-Q · filed 2024-11-07 | $151.44M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $146.76M 10-Q · filed 2024-11-07 | $146.76M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $145.66M 10-Q · filed 2024-11-07 | $145.65M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $151.97M 10-K · filed 2026-02-25 | $151.97M 10-K · filed 2023-03-23 |
| 2022-09-30 | $100.38M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $114.40M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $126.93M 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $141.17M 10-K · filed 2025-03-18 | $141.17M 10-K · filed 2022-03-24 |
| 2021-09-30 | $102.78M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $111.59M 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $112.50M 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $88.25M 10-K · filed 2024-02-28 | $88.25M 10-K · filed 2021-03-25 |
| 2020-09-30 | $71.38M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $76.88M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $96.34M 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $26.19M 10-K · filed 2022-03-24 | |
| 2019-09-30 | $36.12M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $46.91M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $10.04M 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $19.77M 10-K · filed 2021-03-25 | |
| 2018-09-30 | $37.21M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $51.76M 10-Q · filed 2019-11-06 | |
| 2018-03-31 | $23.03M 10-Q · filed 2019-08-08 | |
| 2017-12-31 | $40.33M 10-K · filed 2020-03-13 | |
| 2017-09-30 | $12.99M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $27.68M 10-Q · filed 2017-08-11 | |
| 2017-03-31 | -$10.76M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | -$4.46M 10-K · filed 2019-03-13 | |
| 2016-09-30 | -$152.14K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $3.92M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | -$3.37M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $820.97K 10-K · filed 2018-03-29 | |
| 2015-09-30 | $4.91M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $9.52M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $13.43M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $6.01M 10-K · filed 2017-02-24 | |
| 2014-09-30 | $9.24M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $12.30M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $15.90M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $21.57M 10-K · filed 2016-03-23 | |
| 2013-09-30 | -$735.76K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $1.73M 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $6.40M 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $9.42M 10-K · filed 2015-03-09 | |
| 2012-09-30 | $11.61M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $14.66M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $15.75M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $385.82K 10-K · filed 2013-03-06 | $2.77K 10-Q · filed 2012-02-01 |
| 2011-09-30 | -$3.90K 10-Q · filed 2011-10-28 | |
| 2011-06-30 | -$1.31K 10-Q · filed 2012-02-01 | |
| 2010-12-31 | -$3.93M 10-K · filed 2013-03-06 | |
| 2010-06-30 | -$346.00 10-Q · filed 2012-02-01 | |
| 2009-06-30 | -$2.82K 10-Q · filed 2012-02-01 | |
| 2008-06-30 | -$13.31K 10-Q · filed 2012-02-01 | |
| 2007-06-30 | $4.58K 10-Q · filed 2012-02-01 | |
| 2006-06-30 | $21.77K 10-Q · filed 2012-02-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |